• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Implications of Interleukin-6 (IL-6)-blockade for severe COVID-19 infection in patients with Multiple Myeloma.

作者信息

Sgherza Nicola, Curci Paola, Strafella Vanda, Rizzi Rita, Musto Pellegrino

机构信息

a:1:{s:5:"en_US";s:147:"Hematology and Bone Marrow Transplantation Unit - AOUC Policlinico, Department of Emergency and Organ Transplantation, "Aldo Moro" University, Bari";}.

Hematology and Bone Marrow Transplantation Unit - AOUC Policlinico, Department of Emergency and Organ Transplantation, "Aldo Moro" University, 70124, Bari, Italy.

出版信息

Acta Biomed. 2021 May 12;92(2):e2021205. doi: 10.23750/abm.v92i2.11395.

DOI:10.23750/abm.v92i2.11395
PMID:33988136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8182598/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfd6/8182598/f7a8207bf421/ACTA-92-205-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfd6/8182598/f7a8207bf421/ACTA-92-205-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfd6/8182598/f7a8207bf421/ACTA-92-205-g001.jpg

相似文献

1
Implications of Interleukin-6 (IL-6)-blockade for severe COVID-19 infection in patients with Multiple Myeloma.白细胞介素-6（IL-6）阻断对多发性骨髓瘤患者严重新型冠状病毒肺炎感染的影响
Acta Biomed. 2021 May 12;92(2):e2021205. doi: 10.23750/abm.v92i2.11395.
2
Interleukin 6-blockade treatment for severe COVID-19 in two patients with multiple myeloma.白细胞介素6阻断疗法治疗两名多发性骨髓瘤患者的重症新型冠状病毒肺炎
Br J Haematol. 2020 Jul;190(1):e9-e11. doi: 10.1111/bjh.16787. Epub 2020 May 18.
3
COVID-19 in hem/onc news.血液肿瘤新闻中的新冠病毒肺炎
Clin Adv Hematol Oncol. 2020 May;18(5):248.
4
Myeloma care adaptations in the UK during SARS-CoV-2 pandemic: Challenges and measurable outcomes.英国在新冠疫情期间骨髓瘤护理的调整：挑战与可衡量的结果
Eur J Haematol. 2020 Nov;105(5):662-666. doi: 10.1111/ejh.13479. Epub 2020 Jul 15.
5
Secukinumab in severe COVID-19 pneumonia: Does it have a clinical impact?司库奇尤单抗治疗重症新型冠状病毒肺炎：是否具有临床影响？
J Infect. 2021 Jul;83(1):e11-e13. doi: 10.1016/j.jinf.2021.05.011. Epub 2021 May 21.
6
Anti-BCMA CAR T administration in a relapsed and refractory multiple myeloma patient after COVID-19 infection: a case report.COVID-19 感染后复发/难治性多发性骨髓瘤患者抗 BCMA CAR T 治疗：1 例报告。
J Med Case Rep. 2021 Feb 19;15(1):90. doi: 10.1186/s13256-020-02598-0.
7
Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial.托珠单抗治疗 COVID-19 的疗效：一项非对照、前瞻性临床试验。
Int Immunopharmacol. 2020 Nov;88:106869. doi: 10.1016/j.intimp.2020.106869. Epub 2020 Aug 4.
8
Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.托珠单抗治疗细胞因子风暴综合征的 SARS-CoV-2 患者：一项叙述性综述。
Rev Recent Clin Trials. 2021;16(2):138-145. doi: 10.2174/1574887115666200917110954.
9
Interleukin-6 blockade with tocilizumab in COVID-19: Does it live up to its hype?托珠单抗阻断白细胞介素-6治疗新型冠状病毒肺炎：它是否名副其实？
Pulmonology. 2021 Jan-Feb;27(1):86-87. doi: 10.1016/j.pulmoe.2020.10.004. Epub 2020 Oct 21.
10
Elevated interleukin-6 and severe COVID-19: A meta-analysis.白细胞介素-6升高与重症新型冠状病毒肺炎：一项荟萃分析。
J Med Virol. 2020 Nov;92(11):2283-2285. doi: 10.1002/jmv.25948. Epub 2020 Jun 2.

本文引用的文献

1
Potential Role of Anti-interleukin (IL)-6 Drugs in the Treatment of COVID-19: Rationale, Clinical Evidence and Risks.抗白细胞介素 (IL)-6 药物在 COVID-19 治疗中的潜在作用：原理、临床证据和风险。
BioDrugs. 2020 Aug;34(4):415-422. doi: 10.1007/s40259-020-00430-1.
2
IL-6 Inhibitors in the Treatment of Serious COVID-19: A Promising Therapy?白细胞介素-6抑制剂治疗重症新型冠状病毒肺炎：一种有前景的疗法？
Pharmaceut Med. 2020 Aug;34(4):223-231. doi: 10.1007/s40290-020-00342-z.
3
Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia.
托珠单抗治疗新型冠状病毒肺炎的合理应用。
Clin Drug Investig. 2020 Jun;40(6):511-518. doi: 10.1007/s40261-020-00917-3.
4
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.新型冠状病毒肺炎（SARS-CoV-2）感染的癌症患者：一项中国全国性分析。
Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6. Epub 2020 Feb 14.
5
Successful treatment of a patient with rheumatoid arthritis and IgA-κ multiple myeloma with tocilizumab.用托珠单抗成功治疗一名类风湿性关节炎合并IgA-κ多发性骨髓瘤患者。
Intern Med. 2011;50(6):639-42. doi: 10.2169/internalmedicine.50.4636. Epub 2011 Mar 15.
6
Humanized anti-interleukin-6 receptor monoclonal antibody induced apoptosis of fresh and cloned human myeloma cells in vitro.人源化抗白细胞介素-6受体单克隆抗体在体外诱导新鲜及克隆化人骨髓瘤细胞凋亡。
Leuk Res. 2003 Apr;27(4):343-9. doi: 10.1016/s0145-2126(02)00179-0.